JB Global Capital reported an 8.9% decline in Q4 2025 due to a drop in Alibaba but still delivered a strong full-year return of 67.5%, outperforming major benchmarks. The fund’s focus on fundamentals aims for long-term performance despite avoiding mega-cap tech companies. Check the top five holdings for 2025 insights.

The Clorox Company (NYSE:CLX) is a U.S. consumer goods company with a $6.8 billion portfolio. Despite temporary disruptions from an ERP implementation, the company aims for cost savings and efficiency improvements. The stock trades at 16x earnings, with an estimated fair value implying 30-40% upside. Shares closed at approximately $111.41 on January 14, 2026.

JB Global Capital initiated a position in The Clorox Company (NYSE:CLX) at $104 per share in Q4 2025. The company’s recovery story is gaining momentum despite not being among the most popular stocks among hedge funds. The fund’s conviction lies in AI stocks for higher returns within a shorter timeframe. Check out more investor letters from hedge funds and leading investors for additional insights.

Read more at Yahoo Finance: Here’s Why The Clorox Company (CLX) Recovery Story is Gaining Momentum